Einat Zisman, PhD, MBA appointed to the Hadasit Bio Holdings Board of Directors.
Oct. 18, 2012
Following the shareholders approval at the shareholders meeting on Oct. 18th , Dr. Einat Zisman will serve as a director on the Hadasit Bio-Holdings Ltd. board of directors.
Dr. Zisman is the current CEO of Hadasit Medical Research Services & Development Ltd. a major HBL shareholder (~ 36%). Dr. Zisman serves on the board of a number of companies and previously held the position of VP Business Development at the Weizmann institutes’ tech transfer company, YEDA.
Dr. Zisman has a PhD in Chemistry from the Weizmann institute as well as an MBA from the University of South California.